The eighteenth resolution submits for your approval the renewal of the delegation of authority granted to the Board of Directors in 2024, for a period of twenty-six (26) months, to issue, without preferential subscription rights, financial instruments giving access to the Company’s share capital or in any of its direct or indirect subsidiaries, as the case may be, to remunerate the contribution in kind granted to the Company, except in the case of a public offering.
The purpose of this delegation of authority is to provide the Company with the necessary flexibility to carry out external growth transactions by settling all or part of these acquisitions in securities.
This delegation of authority is subject to the limits set forth in the table on page 62.
The General Shareholders’ Meeting, voting in accordance with the quorum and majority requirements for extraordinary general shareholders’ meetings, having reviewed the Board of Directors’ report and the Statutory Auditors’ special report, and pursuant to Articles L 225-129 et seq. of the French Commercial Code, notably Articles L. 225-129 and L. 225-129-2, and Articles L. 22-10-53 et L. 228-91 et seq. of the French Commercial Code: